More on OGN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $13.70 |
|
|||
| Open | $13.70 | ||||
| 52 Wk High | $8.00 | ||||
| 52 Wk Low | $8.00 | ||||
| Day High | $13.72 | ||||
| Day Low | $13.67 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 2,158,104 | ||||
- Form 4 Organon & Co. For: Aug 11 Filed by: Arjona Ferreira Juan Camilo
- Organon opens REMS enrollment for copper IUD ahead of late 2026 launch
- Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability
- Form 4 Organon & Co. For: Aug 05 Filed by: Drinane Juliana Papa
- Organon (OGN) Declares $0.02 Quarterly Dividend; 0.6% Yield
- Organon Announces Quarterly Dividend
- Organon presents tapinarof cream data across age groups at SPD meeting
- New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults¹
- Altius Provides 2nd Quarter 2026 Project Generation Update
- Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
Entities mentioned with OGN
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Show More...
